IMPROVEMENTS IN ISOLATION HEAD PERFUSION.
D002294:Carcinoma, Squamous Cell; D002339:Carotid Arteries; D010478:Chemotherapy, Cancer, Regional Perfusion; D002648:Child; D002817:Chordoma; D003520:Cyclophosphamide; D005354:Fibrosarcoma; D007035:Hypothermia; D007036:Hypothermia, Induced; D007601:Jugular Veins; D008545:Melanoma; D009369:Neoplasms / Q000628:therapy*; D012516:Osteosarcoma; D011379:Prognosis; D012175:Retinoblastoma; D012208:Rhabdomyosarcoma; D012509:Sarcoma; D014116:Toxicology; D014265:Triethylenemelamine
D003520:Cyclophosphamide; D014265:Triethylenemelamine
CARCINOMA, EPIDERMOID; CAROTID ARTERIES; CHILD; CHORDOMA; CYCLOPHOSPHAMIDE; FIBROSARCOMA; HYPOTHERMIA, INDUCED; ISOLATION PERFUSION; JUGULAR VEIN; MELANOMA; NEOPLASM THERAPY; PROGNOSIS; RETINOBLASTOMA; RHABDOMYOSARCOMA; SARCOMA, OSTEOGENIC; TOXICOLOGIC REPORT; TRIETHYLENE MELAMINE